MedTrace Logo

Evaluation of Biomarkers of Traumatic Brain Injury

NCT01426919 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2011

Last updated 2020-12-16

No results posted yet for this study

Summary

The primary objective of this study is to evaluate the utility of the Banyan UCH-L1/GFAP Detection Assay as an aid in the evaluation of suspected traumatic brain injury (Glasgow Coma Scale score 9-15) in conjunction with other clinical information within 12 hours of injury to assist in determining the need for a CT scan of the head.

Conditions

Interventions

OTHER

Head CT scan and blood draw within 12 hours of injury

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED

  • Banyan Biomarkers, Inc

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2017-07-31
Completion
2017-07-31

Countries

  • United States
  • Germany
  • Hungary

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01426919 on ClinicalTrials.gov